Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for enhancing transport of semiconductor nanocrystals across biological membranes

a technology of semiconductor nanocrystals and biological membranes, applied in the field of semiconductor nanocrystal probes, can solve the problems of complex robotics and fluid dispensing systems, affecting the optimal functioning of fluid delivery and evaporation of assay solution at this scale, and limiting the flexibility of each format, so as to facilitate analysis

Inactive Publication Date: 2005-03-17
INVITROGEN +1
View PDF12 Cites 46 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0013] Methods and compositions for encoding cells with semiconductor nanoparticles such as semiconductor nanocrystals, other fluorescent species, or otherwise detectable species and combinations thereof are provided. In one aspect, a method is provided comprising the ability to separately identify individual populations of cells in a mixture of different types of cells which is highly advantageous for many applications. This method is especially useful for identifying a population of cells derived from an initial sample of one or more cells via its unique spectral code after several cell divisions. The method facilitates analysis of many otherwise identical cells which only differ by the presence or absence of one or more genes and which are subjected to a functional assay.
[0017] The present invention also relates to methods for providing enhanced transport of semiconductor nanoparticles, such as semiconductor nanocrystals across cell membranes, thereby encoding cells which can be used in highly multiplexed assays. The methods of the invention for encoding spectra can be used, for example, in multiplex settings where a plurality of different cell types are encoded and assayed for a phenotype. The large number of distinguishable semiconductor nanoparticles can be employed to simultaneously analyze differently spectrally encoded cells. The methods may be used to enhance transport of semiconductor nanoparticles across any of a number of biological membranes including, but not limited to, eukaryotic cell membranes, prokaryotic cell membranes, and cell walls. The methods are also useful in single-plex type assays, such as to follow cell mobility, for cell tracking and in in vivo applications.
[0019] The ability to detect populations of cells derived from a few precursors by virtue of their spectral code greatly facilitates the high-throughput analysis of many systems. It allows the identification of populations that have multiplied in a particular environment in the absence of any further experimental processing. The number of cells bearing the diluted code can be determined using various spectral scanning devices.
[0021] The invention thus provides a semiconductor nanoparticle complex comprising a semiconductor nanoparticle associated with a cationic polymer capable of enhancing the transport of the semiconductor nanoparticle across a biological membrane.

Problems solved by technology

Each of these formats has limitations, however.
Assays have been reduced in size to accommodate 1536 wells per plate, though the fluid delivery and evaporation of the assay solution at this scale are significantly more problematic.
High-throughput formats based on multi-well arraying require complex robotics and fluid dispensing systems to function optimally.
The dispensing of the appropriate solutions to the appropriate bins on the plate poses a challenge from both an efficiency and a contamination standpoint, and pains must be taken to optimize the fluidics for both properties.
Furthermore, the throughput is ultimately limited by the number of wells that one can put adjacent on a plate, and the volume of each well.
The spatial isolation of each well, and thereby each assay, comes at the cost of the ability to run multiple assays in a single well.
Such single-well multiplexing techniques are not widely used, due in large part to the inability to “demultiplex” or resolve the results of the different assays in a single well.
However, such multiplexing would obviate the need for high-density well assay formats.
Each of the current techniques for ultra-high-throughput assay formats suffers from severe limitations.
However, none of the above-described art pertains to the use of cationic polymers to transport semiconductor nanoparticles across biological membranes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for enhancing transport of semiconductor nanocrystals across biological membranes
  • Method for enhancing transport of semiconductor nanocrystals across biological membranes
  • Method for enhancing transport of semiconductor nanocrystals across biological membranes

Examples

Experimental program
Comparison scheme
Effect test

example 1

Peptide-mediated Uptake of SCNCs

[0344] Chariot (Active Motif, Carlsbad, Calif.) is a peptide reagent based on the HIV-tat sequence (Schwarze et al. (1999) Science 285:1569-1572), and has been used to deliver a variety of macromolecules into cells. Chariot forms a non-covalent complex with a molecule of interest (protein, peptide, antibody, or SCNC), and acts as a carrier to deliver molecules into cells.

[0345] To deliver SCNCs into cells using Chariot, tissue culture cells were seeded into six-well tissue culture plates (surface area of 962 mm2 per well) at a cell density of 3×105 cells per well and incubated overnight at 37° C. in a 5% CO2 atmosphere. The transfection efficiency was dependent on the percent confluency of cells; the optimal percent confluency for Chinese Hamster Ovary (CHO) cells was about 50-70%.

[0346] The transfection mixture was prepared by first diluting 616 nm emitting SCNCs into PBS in a final volume of 100 μl. The diluted SCNCs were combined with a mixture ...

example 2

Nonspecific Uptake of SCNCs

[0348] SCNCs can be internalized by cells in the absence of a specific carrier molecule. Non-crosslinked polymer-coated SCNCs prepared as described above are sufficiently hydrophobic that they bind to cells and are taken up by nonspecific endocytotic pathways. Cells encoded with SCNCs were prepared as described in Example 1, except the Chariot reagent was omitted from the transfection mix. An example of nonspecific uptake of SCNCs is shown in FIG. 11.

example 3

Cationic Lipid-mediated and Micelle-mediated Uptake of SCNCs

[0349] BioPORTER (BioPORTER, Gene Therapy Systems, San Diego, Calif.) is a cationic lipid that is similar to other lipid-based reagents for DNA transfections. It forms ionic interactions with negatively charged groups of a molecule (protein, peptide, antibody, or SCNC), and delivers the molecule into cells via fusion with the cell membrane.

[0350] Cells were seeded at the same density as described in Example 1. A transfection mix, comprised of carboxylated SCNCs and PBS in a final volume of 100 μl, was added to a tube containing 10 μl of dried BioPORTER reagent. The solution was mixed gently by pipetting, incubated at room temperature for 5 minutes, and diluted by adding 900 μl of serum free medium. Cells were washed with PBS, and the diluted SCNC solution (1 ml) was added to the cell monolayer. The final SCNC concentration was 2-60 nM, depending on the cell line and SCNC material being tested. The cells were incubated at ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Digital informationaaaaaaaaaa
Digital informationaaaaaaaaaa
Digital informationaaaaaaaaaa
Login to View More

Abstract

Semiconductor nanoparticle complexes comprising semiconductor nanoparticles in association with cationic polymers are described. Also described are methods for enhancing the transport of semiconductor nanoparticles across biological membranes to provide encoded cells. The methods are particularly useful in multiplex settings where a plurality of encoded cells are to be assayed. Kits comprising reagents for performing such methods are also provided.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a continuation-in-part of U.S. patent application Ser. No. 09 / 972,744, filed Oct. 3, 2001, from which priority is claimed pursuant to 35 U.S.C. §120 and which is incorporated herein by reference in its entirety, which in turn claims the benefit of U.S. Ser. No. 60 / 238,677, filed Oct. 6, 2000, and U.S. Ser. No. 60 / 312,558, filed Aug. 15, 2001, from which applications priority is claimed under 35 USC §119(e)(1) and both of which applications are incorporated herein by reference in their entireties.TECHNICAL FIELD [0002] The present invention relates to semiconductor nanocrystal probes for biological applications, and methods of screening modulators of receptors using encoded cells. The invention also relates to the use of cationic polymers for enhancing the transport of semiconductor nanocrystals across biological membranes. BACKGROUND OF THE INVENTION [0003] Multiplexed assay formats are necessary to meet the demands o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/00C12N5/06G01N33/50G01N33/566G01N33/58
CPCB82Y15/00G01N33/5008G01N33/5014G01N2500/10G01N33/566G01N33/588G01N2333/726G01N33/5076C07K7/06
Inventor BRUCHEZ, MARCELDANIELS, R.DIAS, JENNIFERMATTHEAKIS, LARRYLIU, HONGJIANBURT, AQUANETTECHRISTOFFER, BERNDTLY, DANITH
Owner INVITROGEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products